1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 1:Results of cerebral MR imaging studies in 18 patients with SLS
Patient Sex No. of Studies Age Range, year Myelin Deficit Periventricular Zone of Abnormal Signal Intensity Atrophy Degree Predominance 1 F 3 0.8–1 1 1 PO*† 0 2 M 5 0.4–4 1 1 PO 0 3 M 2 3–5 1 1 PO 0 4 M 3 1–8 1 1 PO 0 5 M 1 8 1 1 PO 0 6 M 2 5–9 1 1 PO 0 7 F 2 6–9 1 1 PO 0 8 M 2 8–9 1 2 FP* 0 9 F 7 3–10 1 1 PO 0 10 F 1 10 1 1 FP* 1 11 F 1 13 1 1 PO† 0 12 F 3 11–14 1 1 PO 0 13 M 4 12–16 1 2 FP 1 14 F 3 12–17 1 1 PO 1 15 F 3 15–17 1 2 FP*† 0 16 F 3 16–21 1 1 PO 1 17 M 1 38 0 1 PO 1 18 F 2 41–45 1 1 PO 1
Note.—The results reflect findings from each patient’s latest MR imaging study. The degree of myelin deficit, periventricular signal-intensity abnormalities, and atrophy were scored as follows: 0 = none, 1 = mild, 2 = severe. PO = parieto-occipital, FP = frontoparietal.
* Corpus callosum involved.
† Patchy white matter lesions.